Arkolith/Insider Trading/ALNY/Form 4

Pyott David E I

DirectorALNYLAM PHARMACEUTICALS, INC. (ALNY) · full profile →Form 4 · filed Jun 3, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.1M
Net Open-Market Flow
-$1.1M
Transactions
7
6 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 1, 2026Option exercise(M)4K—$05K
Jun 1, 2026Sell(S)921$297.71$274K4K
Jun 1, 2026Sell(S)1K$298.91$351K3K
Jun 1, 2026Sell(S)1K$299.87$366K2K
Jun 1, 2026Sell(S)495$300.72$149K2K
Jun 1, 2026Sell(S)17$302.65$5K2K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 1, 2026Option exercise(M)4K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001178670-26-000048) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML